Cargando…

Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment

BACKGROUND AND AIMS: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a newly proposed term based on modified criteria. Although nonalcoholic fatty liver disease (NAFLD) has been well-documented as a multisystem disease, research on the correlation of MAFLD and extra-hepatic diseases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Qiang, He, Ruixin, Jiang, Haowen, Wu, Ji, Xi, Zhifeng, He, Kang, Liu, Yongbo, Zhou, Tao, Feng, Mingxuan, Wan, Ping, Yan, Hexin, Xia, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634777/ https://www.ncbi.nlm.nih.gov/pubmed/36381086 http://dx.doi.org/10.14218/JCTH.2021.00490

Ejemplares similares

Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease
por: Miao, Lei, et al.
Publicado: (2022)

Unusual Ileocecal Ulcers after Liver Transplantation for Hepatitis B Cirrhosis and Hepatocellular Carcinoma
por: He, Kang, et al.
Publicado: (2022)

Genetic variants associated with metabolic dysfunction‐associated fatty liver disease in western China
por: Liao, Shenling, et al.
Publicado: (2022)

Macrophage Polarization and Liver Ischemia-Reperfusion Injury
por: Wang, Hai, et al.
Publicado: (2021)

Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease
por: Bae, Jaehyun, et al.
Publicado: (2023)

Associations between non-alcoholic fatty liver disease and cognitive impairment and the effect modification of inflammation
por: Kang, Sunghyuk, et al.
Publicado: (2022)

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
por: Lee, Sejeong, et al.
Publicado: (2023)

Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation
por: Yang, Mengmeng, et al.
Publicado: (2023)

Liver-specific Mettl3 ablation delays liver regeneration in mice
por: Meng, Jiaxiang, et al.
Publicado: (2020)

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
por: Han, A Lum
Publicado: (2022)

Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms
por: He, Yuan, et al.
Publicado: (2022)

Identification of Liver Immune Microenvironment-Related Hub Genes in Liver of Biliary Atresia
por: Zhang, Jiaxu, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
por: Song, Byeong Geun, et al.
Publicado: (2023)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Low-Carbohydrate and Low-Fat Diet with Metabolic-Dysfunction-Associated Fatty Liver Disease
por: Hu, Chengxiang, et al.
Publicado: (2023)

Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC
por: Liu, Lei, et al.
Publicado: (2022)

CT-based methods for assessment of metabolic dysfunction associated with fatty liver disease
por: Hu, Na, et al.
Publicado: (2023)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya disease
por: Liu, Ziqi, et al.
Publicado: (2020)

Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update
por: Alharthi, Jawaher, et al.
Publicado: (2022)

Therapeutic developments in metabolic dysfunction-associated fatty liver disease
por: Shi, Yiwen, et al.
Publicado: (2022)

Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
por: Perdomo, Carolina M., et al.
Publicado: (2022)

The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
por: Martín-Mateos, Rosa, et al.
Publicado: (2021)

Association of β-Amyloid Burden With Sleep Dysfunction and Cognitive Impairment in Elderly Individuals With Cognitive Disorders
por: You, Jason C., et al.
Publicado: (2019)

Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment
por: Ding, Yuping, et al.
Publicado: (2023)

Patient-derived models facilitate precision medicine in liver cancer by remodeling cell-matrix interaction
por: Chen, Kaiwen, et al.
Publicado: (2023)

A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease
por: Yang, Chengzhang, et al.
Publicado: (2022)

MUC1 promotes lung metastases of liver cancer by impairing anti-tumor immunity
por: Yin, Yanze, et al.
Publicado: (2023)

Parthenolide plays a protective role in the liver of mice with metabolic dysfunction-associated fatty liver disease through the activation of the HIPPO pathway
por: Wang, Weihong, et al.
Publicado: (2021)

Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)
por: Heebøll, Sara, et al.
Publicado: (2022)

Associations between cognitive impairment and motor dysfunction in Parkinson's disease
por: Wang, Yi‐Xuan, et al.
Publicado: (2017)

Association of Olfactory Impairment and Postoperative Cognitive Dysfunction in Elderly Patients
por: Lan, Yang, et al.
Publicado: (2021)

Reward network dysfunction is associated with cognitive impairment after stroke
por: Wagner, Franziska, et al.
Publicado: (2023)

Association of food intake with a risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study
por: Huang, Xian-Hua, et al.
Publicado: (2023)

7 Association of Non-Alcoholic Fatty Liver Disease (NAFLD) with Mild Cognitive Impairment (MCI) in Aging Hispanics
por: Miranda-Enchautegui, Antonio, et al.
Publicado: (2023)

Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease
por: Fiorillo, Alessandra, et al.
Publicado: (2023)

Low–Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Zuarth-Vázquez, Julia, et al.
Publicado: (2023)

FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
por: Gu, Zhan, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
por: Balta, Sevket, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ofk93dlgjmdrturo816ic52t11